nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—VDR—hindlimb—muscle cancer	0.0671	0.251	CbGeAlD
Paricalcitol—VDR—appendage—muscle cancer	0.0575	0.215	CbGeAlD
Paricalcitol—CYP24A1—renal system—muscle cancer	0.0263	0.0983	CbGeAlD
Paricalcitol—UGT1A4—renal system—muscle cancer	0.0263	0.0983	CbGeAlD
Paricalcitol—CYP24A1—vagina—muscle cancer	0.019	0.0712	CbGeAlD
Paricalcitol—VDR—renal system—muscle cancer	0.0145	0.0541	CbGeAlD
Paricalcitol—VDR—tendon—muscle cancer	0.0113	0.0422	CbGeAlD
Paricalcitol—VDR—bone marrow—muscle cancer	0.0109	0.0409	CbGeAlD
Paricalcitol—VDR—vagina—muscle cancer	0.0105	0.0392	CbGeAlD
Paricalcitol—VDR—head—muscle cancer	0.00968	0.0362	CbGeAlD
Paricalcitol—VDR—testis—muscle cancer	0.00935	0.035	CbGeAlD
Paricalcitol—CYP3A4—renal system—muscle cancer	0.00483	0.0181	CbGeAlD
Paricalcitol—Osteoarthritis—Methotrexate—muscle cancer	0.00232	0.00317	CcSEcCtD
Paricalcitol—Nervous system disorder—Vincristine—muscle cancer	0.00231	0.00315	CcSEcCtD
Paricalcitol—Decreased appetite—Dactinomycin—muscle cancer	0.00229	0.00313	CcSEcCtD
Paricalcitol—Dysgeusia—Etoposide—muscle cancer	0.00229	0.00312	CcSEcCtD
Paricalcitol—Hyperhidrosis—Vincristine—muscle cancer	0.00228	0.00311	CcSEcCtD
Paricalcitol—Fatigue—Dactinomycin—muscle cancer	0.00227	0.0031	CcSEcCtD
Paricalcitol—Back pain—Etoposide—muscle cancer	0.00226	0.00308	CcSEcCtD
Paricalcitol—Pain—Dactinomycin—muscle cancer	0.00225	0.00307	CcSEcCtD
Paricalcitol—Muscle spasms—Etoposide—muscle cancer	0.00225	0.00307	CcSEcCtD
Paricalcitol—Anorexia—Vincristine—muscle cancer	0.00224	0.00306	CcSEcCtD
Paricalcitol—Hypotension—Vincristine—muscle cancer	0.0022	0.003	CcSEcCtD
Paricalcitol—Feeling abnormal—Dactinomycin—muscle cancer	0.00217	0.00296	CcSEcCtD
Paricalcitol—Ill-defined disorder—Etoposide—muscle cancer	0.00217	0.00296	CcSEcCtD
Paricalcitol—Anaemia—Etoposide—muscle cancer	0.00216	0.00295	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00215	0.00294	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00214	0.00293	CcSEcCtD
Paricalcitol—Insomnia—Vincristine—muscle cancer	0.00213	0.00291	CcSEcCtD
Paricalcitol—Paraesthesia—Vincristine—muscle cancer	0.00211	0.00288	CcSEcCtD
Paricalcitol—Malaise—Etoposide—muscle cancer	0.00211	0.00288	CcSEcCtD
Paricalcitol—Dermatitis bullous—Doxorubicin—muscle cancer	0.00211	0.00287	CcSEcCtD
Paricalcitol—Breast disorder—Methotrexate—muscle cancer	0.0021	0.00287	CcSEcCtD
Paricalcitol—Vertigo—Etoposide—muscle cancer	0.0021	0.00286	CcSEcCtD
Paricalcitol—Leukopenia—Etoposide—muscle cancer	0.00209	0.00285	CcSEcCtD
Paricalcitol—Abdominal pain—Dactinomycin—muscle cancer	0.00208	0.00284	CcSEcCtD
Paricalcitol—Body temperature increased—Dactinomycin—muscle cancer	0.00208	0.00284	CcSEcCtD
Paricalcitol—Hypoglycaemia—Doxorubicin—muscle cancer	0.00206	0.00281	CcSEcCtD
Paricalcitol—Loss of consciousness—Etoposide—muscle cancer	0.00205	0.0028	CcSEcCtD
Paricalcitol—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00205	0.0028	CcSEcCtD
Paricalcitol—Decreased appetite—Vincristine—muscle cancer	0.00205	0.00279	CcSEcCtD
Paricalcitol—Cough—Etoposide—muscle cancer	0.00204	0.00278	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Vincristine—muscle cancer	0.00203	0.00277	CcSEcCtD
Paricalcitol—Fatigue—Vincristine—muscle cancer	0.00203	0.00277	CcSEcCtD
Paricalcitol—Hypertension—Etoposide—muscle cancer	0.00202	0.00275	CcSEcCtD
Paricalcitol—Pain—Vincristine—muscle cancer	0.00201	0.00275	CcSEcCtD
Paricalcitol—Constipation—Vincristine—muscle cancer	0.00201	0.00275	CcSEcCtD
Paricalcitol—Osteoarthritis—Doxorubicin—muscle cancer	0.00201	0.00275	CcSEcCtD
Paricalcitol—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00201	0.00275	CcSEcCtD
Paricalcitol—Asthma—Methotrexate—muscle cancer	0.00201	0.00274	CcSEcCtD
Paricalcitol—Chest pain—Etoposide—muscle cancer	0.00199	0.00271	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00198	0.0027	CcSEcCtD
Paricalcitol—Pancreatitis—Methotrexate—muscle cancer	0.00197	0.00269	CcSEcCtD
Paricalcitol—Discomfort—Etoposide—muscle cancer	0.00197	0.00268	CcSEcCtD
Paricalcitol—Hypersensitivity—Dactinomycin—muscle cancer	0.00194	0.00265	CcSEcCtD
Paricalcitol—Abdominal discomfort—Methotrexate—muscle cancer	0.00193	0.00263	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Vincristine—muscle cancer	0.00192	0.00263	CcSEcCtD
Paricalcitol—Confusional state—Etoposide—muscle cancer	0.00192	0.00262	CcSEcCtD
Paricalcitol—Cardiac arrest—Doxorubicin—muscle cancer	0.00191	0.00261	CcSEcCtD
Paricalcitol—Infection—Etoposide—muscle cancer	0.00189	0.00259	CcSEcCtD
Paricalcitol—Asthenia—Dactinomycin—muscle cancer	0.00189	0.00258	CcSEcCtD
Paricalcitol—Dehydration—Doxorubicin—muscle cancer	0.00187	0.00255	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00187	0.00255	CcSEcCtD
Paricalcitol—Abdominal pain—Vincristine—muscle cancer	0.00186	0.00254	CcSEcCtD
Paricalcitol—Body temperature increased—Vincristine—muscle cancer	0.00186	0.00254	CcSEcCtD
Paricalcitol—Skin disorder—Etoposide—muscle cancer	0.00185	0.00253	CcSEcCtD
Paricalcitol—Erectile dysfunction—Methotrexate—muscle cancer	0.00185	0.00252	CcSEcCtD
Paricalcitol—Hyperhidrosis—Etoposide—muscle cancer	0.00184	0.00252	CcSEcCtD
Paricalcitol—Breast disorder—Doxorubicin—muscle cancer	0.00182	0.00248	CcSEcCtD
Paricalcitol—Anorexia—Etoposide—muscle cancer	0.00182	0.00248	CcSEcCtD
Paricalcitol—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00181	0.00247	CcSEcCtD
Paricalcitol—Diarrhoea—Dactinomycin—muscle cancer	0.0018	0.00246	CcSEcCtD
Paricalcitol—Pneumonia—Methotrexate—muscle cancer	0.0018	0.00246	CcSEcCtD
Paricalcitol—Nasopharyngitis—Doxorubicin—muscle cancer	0.0018	0.00246	CcSEcCtD
Paricalcitol—Infestation NOS—Methotrexate—muscle cancer	0.00179	0.00244	CcSEcCtD
Paricalcitol—Infestation—Methotrexate—muscle cancer	0.00179	0.00244	CcSEcCtD
Paricalcitol—Depression—Methotrexate—muscle cancer	0.00179	0.00244	CcSEcCtD
Paricalcitol—Hypotension—Etoposide—muscle cancer	0.00178	0.00243	CcSEcCtD
Paricalcitol—Gastritis—Doxorubicin—muscle cancer	0.00178	0.00243	CcSEcCtD
Paricalcitol—Conjunctivitis—Methotrexate—muscle cancer	0.00174	0.00238	CcSEcCtD
Paricalcitol—Influenza—Doxorubicin—muscle cancer	0.00174	0.00237	CcSEcCtD
Paricalcitol—Asthma—Doxorubicin—muscle cancer	0.00174	0.00237	CcSEcCtD
Paricalcitol—Dysphagia—Doxorubicin—muscle cancer	0.00174	0.00237	CcSEcCtD
Paricalcitol—Hypersensitivity—Vincristine—muscle cancer	0.00173	0.00237	CcSEcCtD
Paricalcitol—Sweating—Methotrexate—muscle cancer	0.00172	0.00234	CcSEcCtD
Paricalcitol—Paraesthesia—Etoposide—muscle cancer	0.00171	0.00234	CcSEcCtD
Paricalcitol—Pancreatitis—Doxorubicin—muscle cancer	0.00171	0.00233	CcSEcCtD
Paricalcitol—Dyspnoea—Etoposide—muscle cancer	0.0017	0.00232	CcSEcCtD
Paricalcitol—Somnolence—Etoposide—muscle cancer	0.0017	0.00231	CcSEcCtD
Paricalcitol—Epistaxis—Methotrexate—muscle cancer	0.00169	0.00231	CcSEcCtD
Paricalcitol—Asthenia—Vincristine—muscle cancer	0.00169	0.0023	CcSEcCtD
Paricalcitol—Vomiting—Dactinomycin—muscle cancer	0.00168	0.00229	CcSEcCtD
Paricalcitol—Rash—Dactinomycin—muscle cancer	0.00166	0.00227	CcSEcCtD
Paricalcitol—Decreased appetite—Etoposide—muscle cancer	0.00166	0.00226	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Etoposide—muscle cancer	0.00165	0.00225	CcSEcCtD
Paricalcitol—Fatigue—Etoposide—muscle cancer	0.00164	0.00224	CcSEcCtD
Paricalcitol—Constipation—Etoposide—muscle cancer	0.00163	0.00223	CcSEcCtD
Paricalcitol—Pain—Etoposide—muscle cancer	0.00163	0.00223	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00162	0.00221	CcSEcCtD
Paricalcitol—Diarrhoea—Vincristine—muscle cancer	0.00161	0.0022	CcSEcCtD
Paricalcitol—Pharyngitis—Methotrexate—muscle cancer	0.0016	0.00218	CcSEcCtD
Paricalcitol—Urinary tract disorder—Methotrexate—muscle cancer	0.00159	0.00217	CcSEcCtD
Paricalcitol—Urethral disorder—Methotrexate—muscle cancer	0.00158	0.00215	CcSEcCtD
Paricalcitol—Weight decreased—Doxorubicin—muscle cancer	0.00157	0.00215	CcSEcCtD
Paricalcitol—Feeling abnormal—Etoposide—muscle cancer	0.00157	0.00214	CcSEcCtD
Paricalcitol—Nausea—Dactinomycin—muscle cancer	0.00156	0.00214	CcSEcCtD
Paricalcitol—Pneumonia—Doxorubicin—muscle cancer	0.00156	0.00213	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Etoposide—muscle cancer	0.00156	0.00213	CcSEcCtD
Paricalcitol—Dizziness—Vincristine—muscle cancer	0.00156	0.00212	CcSEcCtD
Paricalcitol—Infestation NOS—Doxorubicin—muscle cancer	0.00155	0.00212	CcSEcCtD
Paricalcitol—Infestation—Doxorubicin—muscle cancer	0.00155	0.00212	CcSEcCtD
Paricalcitol—Urticaria—Etoposide—muscle cancer	0.00151	0.00207	CcSEcCtD
Paricalcitol—Abdominal pain—Etoposide—muscle cancer	0.00151	0.00206	CcSEcCtD
Paricalcitol—Body temperature increased—Etoposide—muscle cancer	0.00151	0.00206	CcSEcCtD
Paricalcitol—Conjunctivitis—Doxorubicin—muscle cancer	0.00151	0.00206	CcSEcCtD
Paricalcitol—Urinary tract infection—Doxorubicin—muscle cancer	0.00151	0.00206	CcSEcCtD
Paricalcitol—Eye disorder—Methotrexate—muscle cancer	0.0015	0.00205	CcSEcCtD
Paricalcitol—Vomiting—Vincristine—muscle cancer	0.0015	0.00204	CcSEcCtD
Paricalcitol—Cardiac disorder—Methotrexate—muscle cancer	0.00149	0.00204	CcSEcCtD
Paricalcitol—Sweating—Doxorubicin—muscle cancer	0.00149	0.00203	CcSEcCtD
Paricalcitol—Rash—Vincristine—muscle cancer	0.00148	0.00203	CcSEcCtD
Paricalcitol—Dermatitis—Vincristine—muscle cancer	0.00148	0.00202	CcSEcCtD
Paricalcitol—Headache—Vincristine—muscle cancer	0.00147	0.00201	CcSEcCtD
Paricalcitol—Epistaxis—Doxorubicin—muscle cancer	0.00146	0.002	CcSEcCtD
Paricalcitol—Angiopathy—Methotrexate—muscle cancer	0.00146	0.00199	CcSEcCtD
Paricalcitol—Sinusitis—Doxorubicin—muscle cancer	0.00145	0.00199	CcSEcCtD
Paricalcitol—Immune system disorder—Methotrexate—muscle cancer	0.00145	0.00198	CcSEcCtD
Paricalcitol—Mediastinal disorder—Methotrexate—muscle cancer	0.00145	0.00198	CcSEcCtD
Paricalcitol—Chills—Methotrexate—muscle cancer	0.00144	0.00197	CcSEcCtD
Paricalcitol—Alopecia—Methotrexate—muscle cancer	0.00142	0.00194	CcSEcCtD
Paricalcitol—Mental disorder—Methotrexate—muscle cancer	0.00141	0.00192	CcSEcCtD
Paricalcitol—Hypersensitivity—Etoposide—muscle cancer	0.0014	0.00192	CcSEcCtD
Paricalcitol—Malnutrition—Methotrexate—muscle cancer	0.0014	0.00191	CcSEcCtD
Paricalcitol—Nausea—Vincristine—muscle cancer	0.0014	0.00191	CcSEcCtD
Paricalcitol—Hypoaesthesia—Doxorubicin—muscle cancer	0.00139	0.00189	CcSEcCtD
Paricalcitol—Pharyngitis—Doxorubicin—muscle cancer	0.00138	0.00189	CcSEcCtD
Paricalcitol—Urinary tract disorder—Doxorubicin—muscle cancer	0.00137	0.00188	CcSEcCtD
Paricalcitol—Oedema peripheral—Doxorubicin—muscle cancer	0.00137	0.00187	CcSEcCtD
Paricalcitol—Dysgeusia—Methotrexate—muscle cancer	0.00137	0.00187	CcSEcCtD
Paricalcitol—Asthenia—Etoposide—muscle cancer	0.00137	0.00187	CcSEcCtD
Paricalcitol—Connective tissue disorder—Doxorubicin—muscle cancer	0.00137	0.00187	CcSEcCtD
Paricalcitol—Urethral disorder—Doxorubicin—muscle cancer	0.00136	0.00186	CcSEcCtD
Paricalcitol—Back pain—Methotrexate—muscle cancer	0.00135	0.00185	CcSEcCtD
Paricalcitol—Pruritus—Etoposide—muscle cancer	0.00135	0.00184	CcSEcCtD
Paricalcitol—Diarrhoea—Etoposide—muscle cancer	0.0013	0.00178	CcSEcCtD
Paricalcitol—Eye disorder—Doxorubicin—muscle cancer	0.0013	0.00178	CcSEcCtD
Paricalcitol—Ill-defined disorder—Methotrexate—muscle cancer	0.0013	0.00177	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—muscle cancer	0.00129	0.00177	CcSEcCtD
Paricalcitol—Cardiac disorder—Doxorubicin—muscle cancer	0.00129	0.00176	CcSEcCtD
Paricalcitol—Angiopathy—Doxorubicin—muscle cancer	0.00126	0.00172	CcSEcCtD
Paricalcitol—Malaise—Methotrexate—muscle cancer	0.00126	0.00172	CcSEcCtD
Paricalcitol—Dizziness—Etoposide—muscle cancer	0.00126	0.00172	CcSEcCtD
Paricalcitol—Immune system disorder—Doxorubicin—muscle cancer	0.00126	0.00172	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—muscle cancer	0.00126	0.00172	CcSEcCtD
Paricalcitol—Mediastinal disorder—Doxorubicin—muscle cancer	0.00125	0.00171	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—muscle cancer	0.00125	0.00171	CcSEcCtD
Paricalcitol—Chills—Doxorubicin—muscle cancer	0.00125	0.0017	CcSEcCtD
Paricalcitol—Arrhythmia—Doxorubicin—muscle cancer	0.00124	0.0017	CcSEcCtD
Paricalcitol—Alopecia—Doxorubicin—muscle cancer	0.00123	0.00168	CcSEcCtD
Paricalcitol—Cough—Methotrexate—muscle cancer	0.00122	0.00167	CcSEcCtD
Paricalcitol—Mental disorder—Doxorubicin—muscle cancer	0.00122	0.00166	CcSEcCtD
Paricalcitol—Vomiting—Etoposide—muscle cancer	0.00121	0.00165	CcSEcCtD
Paricalcitol—Malnutrition—Doxorubicin—muscle cancer	0.00121	0.00165	CcSEcCtD
Paricalcitol—Rash—Etoposide—muscle cancer	0.0012	0.00164	CcSEcCtD
Paricalcitol—Dermatitis—Etoposide—muscle cancer	0.0012	0.00164	CcSEcCtD
Paricalcitol—Headache—Etoposide—muscle cancer	0.00119	0.00163	CcSEcCtD
Paricalcitol—Myalgia—Methotrexate—muscle cancer	0.00119	0.00163	CcSEcCtD
Paricalcitol—Chest pain—Methotrexate—muscle cancer	0.00119	0.00163	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—muscle cancer	0.00119	0.00163	CcSEcCtD
Paricalcitol—Tension—Doxorubicin—muscle cancer	0.00119	0.00162	CcSEcCtD
Paricalcitol—Dysgeusia—Doxorubicin—muscle cancer	0.00119	0.00162	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00118	0.00161	CcSEcCtD
Paricalcitol—Discomfort—Methotrexate—muscle cancer	0.00118	0.00161	CcSEcCtD
Paricalcitol—Nervousness—Doxorubicin—muscle cancer	0.00118	0.00161	CcSEcCtD
Paricalcitol—Back pain—Doxorubicin—muscle cancer	0.00117	0.0016	CcSEcCtD
Paricalcitol—Muscle spasms—Doxorubicin—muscle cancer	0.00117	0.00159	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—muscle cancer	0.00115	0.00157	CcSEcCtD
Paricalcitol—Infection—Methotrexate—muscle cancer	0.00113	0.00155	CcSEcCtD
Paricalcitol—Nausea—Etoposide—muscle cancer	0.00113	0.00155	CcSEcCtD
Paricalcitol—Ill-defined disorder—Doxorubicin—muscle cancer	0.00112	0.00153	CcSEcCtD
Paricalcitol—Nervous system disorder—Methotrexate—muscle cancer	0.00112	0.00153	CcSEcCtD
Paricalcitol—Anaemia—Doxorubicin—muscle cancer	0.00112	0.00153	CcSEcCtD
Paricalcitol—Agitation—Doxorubicin—muscle cancer	0.00111	0.00152	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—muscle cancer	0.00111	0.00151	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methotrexate—muscle cancer	0.0011	0.00151	CcSEcCtD
Paricalcitol—Malaise—Doxorubicin—muscle cancer	0.00109	0.00149	CcSEcCtD
Paricalcitol—Vertigo—Doxorubicin—muscle cancer	0.00109	0.00149	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—muscle cancer	0.00109	0.00149	CcSEcCtD
Paricalcitol—Syncope—Doxorubicin—muscle cancer	0.00109	0.00148	CcSEcCtD
Paricalcitol—Leukopenia—Doxorubicin—muscle cancer	0.00108	0.00148	CcSEcCtD
Paricalcitol—Palpitations—Doxorubicin—muscle cancer	0.00107	0.00146	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—muscle cancer	0.00107	0.00146	CcSEcCtD
Paricalcitol—Loss of consciousness—Doxorubicin—muscle cancer	0.00107	0.00145	CcSEcCtD
Paricalcitol—Cough—Doxorubicin—muscle cancer	0.00106	0.00144	CcSEcCtD
Paricalcitol—Hypertension—Doxorubicin—muscle cancer	0.00105	0.00143	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00104	0.00142	CcSEcCtD
Paricalcitol—Insomnia—Methotrexate—muscle cancer	0.00103	0.00141	CcSEcCtD
Paricalcitol—Chest pain—Doxorubicin—muscle cancer	0.00103	0.00141	CcSEcCtD
Paricalcitol—Arthralgia—Doxorubicin—muscle cancer	0.00103	0.00141	CcSEcCtD
Paricalcitol—Myalgia—Doxorubicin—muscle cancer	0.00103	0.00141	CcSEcCtD
Paricalcitol—Anxiety—Doxorubicin—muscle cancer	0.00103	0.0014	CcSEcCtD
Paricalcitol—Paraesthesia—Methotrexate—muscle cancer	0.00103	0.0014	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00102	0.0014	CcSEcCtD
Paricalcitol—Discomfort—Doxorubicin—muscle cancer	0.00102	0.00139	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—muscle cancer	0.00102	0.00139	CcSEcCtD
Paricalcitol—Somnolence—Methotrexate—muscle cancer	0.00102	0.00139	CcSEcCtD
Paricalcitol—Dry mouth—Doxorubicin—muscle cancer	0.00101	0.00138	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—muscle cancer	0.00101	0.00137	CcSEcCtD
Paricalcitol—Confusional state—Doxorubicin—muscle cancer	0.000997	0.00136	CcSEcCtD
Paricalcitol—Decreased appetite—Methotrexate—muscle cancer	0.000993	0.00135	CcSEcCtD
Paricalcitol—Oedema—Doxorubicin—muscle cancer	0.000989	0.00135	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000986	0.00135	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—muscle cancer	0.000985	0.00134	CcSEcCtD
Paricalcitol—Infection—Doxorubicin—muscle cancer	0.000983	0.00134	CcSEcCtD
Paricalcitol—Pain—Methotrexate—muscle cancer	0.000977	0.00133	CcSEcCtD
Paricalcitol—Shock—Doxorubicin—muscle cancer	0.000973	0.00133	CcSEcCtD
Paricalcitol—Nervous system disorder—Doxorubicin—muscle cancer	0.00097	0.00132	CcSEcCtD
Paricalcitol—Skin disorder—Doxorubicin—muscle cancer	0.000961	0.00131	CcSEcCtD
Paricalcitol—Hyperhidrosis—Doxorubicin—muscle cancer	0.000956	0.0013	CcSEcCtD
Paricalcitol—Anorexia—Doxorubicin—muscle cancer	0.000943	0.00129	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—muscle cancer	0.000941	0.00128	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methotrexate—muscle cancer	0.000934	0.00127	CcSEcCtD
Paricalcitol—Hypotension—Doxorubicin—muscle cancer	0.000924	0.00126	CcSEcCtD
Paricalcitol—Urticaria—Methotrexate—muscle cancer	0.000907	0.00124	CcSEcCtD
Paricalcitol—Body temperature increased—Methotrexate—muscle cancer	0.000903	0.00123	CcSEcCtD
Paricalcitol—Abdominal pain—Methotrexate—muscle cancer	0.000903	0.00123	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000901	0.00123	CcSEcCtD
Paricalcitol—Insomnia—Doxorubicin—muscle cancer	0.000894	0.00122	CcSEcCtD
Paricalcitol—Paraesthesia—Doxorubicin—muscle cancer	0.000888	0.00121	CcSEcCtD
Paricalcitol—Dyspnoea—Doxorubicin—muscle cancer	0.000882	0.0012	CcSEcCtD
Paricalcitol—Somnolence—Doxorubicin—muscle cancer	0.000879	0.0012	CcSEcCtD
Paricalcitol—Dyspepsia—Doxorubicin—muscle cancer	0.000871	0.00119	CcSEcCtD
Paricalcitol—Decreased appetite—Doxorubicin—muscle cancer	0.00086	0.00117	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000854	0.00117	CcSEcCtD
Paricalcitol—Fatigue—Doxorubicin—muscle cancer	0.000853	0.00116	CcSEcCtD
Paricalcitol—Pain—Doxorubicin—muscle cancer	0.000846	0.00115	CcSEcCtD
Paricalcitol—Constipation—Doxorubicin—muscle cancer	0.000846	0.00115	CcSEcCtD
Paricalcitol—Hypersensitivity—Methotrexate—muscle cancer	0.000841	0.00115	CcSEcCtD
Paricalcitol—Asthenia—Methotrexate—muscle cancer	0.000819	0.00112	CcSEcCtD
Paricalcitol—Feeling abnormal—Doxorubicin—muscle cancer	0.000815	0.00111	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000809	0.0011	CcSEcCtD
Paricalcitol—Pruritus—Methotrexate—muscle cancer	0.000808	0.0011	CcSEcCtD
Paricalcitol—Urticaria—Doxorubicin—muscle cancer	0.000786	0.00107	CcSEcCtD
Paricalcitol—Abdominal pain—Doxorubicin—muscle cancer	0.000782	0.00107	CcSEcCtD
Paricalcitol—Body temperature increased—Doxorubicin—muscle cancer	0.000782	0.00107	CcSEcCtD
Paricalcitol—Diarrhoea—Methotrexate—muscle cancer	0.000781	0.00107	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—muscle cancer	0.000755	0.00103	CcSEcCtD
Paricalcitol—Hypersensitivity—Doxorubicin—muscle cancer	0.000729	0.000994	CcSEcCtD
Paricalcitol—Vomiting—Methotrexate—muscle cancer	0.000726	0.000991	CcSEcCtD
Paricalcitol—Rash—Methotrexate—muscle cancer	0.00072	0.000983	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—muscle cancer	0.000719	0.000982	CcSEcCtD
Paricalcitol—Headache—Methotrexate—muscle cancer	0.000716	0.000976	CcSEcCtD
Paricalcitol—Asthenia—Doxorubicin—muscle cancer	0.00071	0.000968	CcSEcCtD
Paricalcitol—Pruritus—Doxorubicin—muscle cancer	0.0007	0.000955	CcSEcCtD
Paricalcitol—Nausea—Methotrexate—muscle cancer	0.000678	0.000926	CcSEcCtD
Paricalcitol—Diarrhoea—Doxorubicin—muscle cancer	0.000677	0.000923	CcSEcCtD
Paricalcitol—Dizziness—Doxorubicin—muscle cancer	0.000654	0.000892	CcSEcCtD
Paricalcitol—Vomiting—Doxorubicin—muscle cancer	0.000629	0.000858	CcSEcCtD
Paricalcitol—Rash—Doxorubicin—muscle cancer	0.000624	0.000851	CcSEcCtD
Paricalcitol—Dermatitis—Doxorubicin—muscle cancer	0.000623	0.00085	CcSEcCtD
Paricalcitol—Headache—Doxorubicin—muscle cancer	0.00062	0.000845	CcSEcCtD
Paricalcitol—Nausea—Doxorubicin—muscle cancer	0.000587	0.000802	CcSEcCtD
